Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical management of BRCA1 and BRCA2 mutation carriers.

Current oncology reports - 1 Jan 2008

Gulati Anthony P, Domchek Susan M

Abstract excerpt

Mutations in the cancer susceptibility genes BRCA1 and BRCA2 are associated with significantly increased risks of breast and ovarian cancer. Fortunately, effective strategies are available to reduce these risks, including genetic testing, which is an important consideration in determining management of patients with a strong family history of cancer. This article reviews the current evidence for risk-reducing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticarcinogenic Agents
Share to Chemoprevention
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Mass Screening

Share to Mastectomy

Share to Ovariectomy

Share to Risk Reduction Behavior

Source

Identifiers

PMID: 18366960
DOI: 10.1007/s11912-008-0008-9

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical management of BRCA1 and BRCA2 mutation carriers.PMID 18366960Read ↗

Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer.Semantic proximity Read ↗

Clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Evaluation and management of women with BRCA1/2 mutations.Semantic proximity Read ↗

Management options after prophylactic surgeries in women with BRCA mutations: a review.Semantic proximity Read ↗

Clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

The counseling and management of young healthy BRCA mutation carriers.Semantic proximity Read ↗

Clinical Considerations of<i>BRCA1</i>- and<i>BRCA2</i>-Mutation Carriers: A ReviewSemantic proximity Read ↗

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.Semantic proximity Read ↗

Risk management decisions in women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.